Molecular Partners Company
Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.
Industry:
PharmTech
Headquarters:
Zurich
Estimated Revenue:
$10M to $50M
Register and Claim Ownership